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In Brief
Obesity and hyperinsulinemia are risk
factors for asthma, but the mechanisms
underlying this association have not been
elucidated. Leiria et al. demonstrate that
increased levels of insulin trigger a
signaling pathway through cholinergic
neurons in the brain stem that can
increase airway reactivity in obese mice.
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Obesity is a major risk factor for asthma, which is
characterized by airway hyperreactivity (AHR). In
obesity-associated asthma, AHR may be regulated
by non-TH2 mechanisms. We hypothesized that
airway reactivity is regulated by insulin in the CNS,
and that the high levels of insulin associated with
obesity contribute to AHR. We found that intracere-
broventricular (ICV)-injected insulin increases airway
reactivity in wild-type, but not in vesicle acetylcholine
transporter knockdown (VAChT KDHOM/), mice.
Either neutralization of central insulin or inhibition of
extracellular signal-regulated kinases (ERK) normal-
ized airway reactivity in hyperinsulinemic obese
mice. These effects were mediated by insulin in
cholinergic nerves located at the dorsal motor nu-
cleus of the vagus (DMV) and nucleus ambiguus
(NA), which convey parasympathetic outflow to the
lungs. We propose that increased insulin-induced
activation of ERK in parasympathetic pre-ganglionic
nerves contributes to AHR in obesemice, suggesting
a drug-treatable link between obesity and asthma.
INTRODUCTION
Recent studies have provided clinical and experimental evi-
dence for a common association between obesity and asthma
(Al-Alwan et al., 2014; Dixon et al., 2011; Sideleva et al., 2012;
Wenzel, 2012). In themost common asthma phenotypes, allergic
asthma accompanied by pulmonary eosinophilic infiltration is re-
garded as the major cause of bronchoconstriction. On the other
hand, obesity-associated asthma is not always accompanied by934 Cell Reports 11, 934–943, May 12, 2015 ª2015 The Authorsthe classic T-helper 2 (TH2) inflammation in the bronchial walls,
and affected subjects are often resistant to first-line glucocorti-
coid drugs (Leiria et al., 2015; Peters-Golden et al., 2006).
Thus, a TH2-independent mechanism is likely to contribute to
airway hyperreactivity (AHR) in obesity.
An emerging line of clinical and epidemiological investigation
has proposed a positive correlation between hyperinsulinemia
and asthma independent of the body mass index (Arshi et al.,
2010; Husemoen et al., 2008; Thuesen et al., 2009). Accord-
ingly, in the context of the pathophysiology of obesity-related
asthma, hyperinsulinemia and insulin resistance would not be
only predictors, but also risk factors for asthma in children
and adults (Husemoen et al., 2008; Thuesen et al., 2009). Inter-
estingly, a recent study has shown that central leptin (an
important hormone involved in the pathogenesis of obesity/
diabetes) is capable of increasing the airways’ diameter via a
negative regulation of the airway-related pre-ganglionic para-
sympathetic fibers (ARPFs) (Arteaga-Solis et al., 2013). More-
over, under extreme body weight condition, leptin resistance
was reported to contribute to AHR in high-fat-fed obese
mice, suggesting that a neuroendocrine mechanism is capable
of regulating AHR under obesity condition (Arteaga-Solis et al.,
2013).
Cholinergic ARPF arises primarily from the rostral nucleus am-
biguus (rNA) and to a lesser degree from the dorsal motor nu-
cleus of the vagus (DMV), both of which are located at the brain
stem (Fonta´n et al., 2000; Pe´rez Fonta´n and Velloff, 2001). The
brain stem ARPFs are the final common pathway from the brain
to the lungs, and, once fired, ARPFs transmit signals to the
intrinsic tracheobronchial ganglia, which lie in close proximity
to the effector tissue (Baker et al., 1986; Dey et al., 1996; Maize
et al., 1998). Finally, postganglionic neurons convey the signal up
to the airway neuroeffector site, where acetylcholine (ACh) is
then released to increase the airway’s tonus (Arteaga-Solis
et al., 2013).
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Figure 1. HFD-Induced Obesity Produces AHR in Mice
(A–E) Measurements of (A) Rrs, (B) Raw, (C) Gtis, (D) Ers, and (E) Htis in control and DIO groups are shown (*p < 0.05, **p < 0.01, ***p < 0.001 compared to control
group; n = 8).
(F–K) Representative images of histology for the lungs from DIO and control groups stained with (F and G) H&E, (H and I) picrosirius red staining (PRS), and (J and
K) oxidized resorcin fuchsin (ORF) are shown.
(L and M) Quantifications of (L) collagen and (M) elastic tissue contents are shown (scale bars, 100 mm; n = 8).
(N) Concentration-response curves to methacholine in isolated bronchial rings from both DIO and control groups are shown (n = 6). All data are expressed as
mean ± SEM.
See also Figure S1.The direct actions of insulin onmetabolic tissues are crucial for
whole-body metabolic homeostasis. However, several central
insulin actions also have been recognized to control important
aspects of glucose and fat metabolism (Bru¨ning et al., 2000;
Koch et al., 2008; Myers and Olson, 2012; Rother et al., 2012).
Endogenous insulin crosses the blood-brain barrier through a
saturable, insulin receptor (IR)-mediated process in brain capil-
lary endothelial cells (Baura et al., 1993; Calhau et al., 2002),
thus explaining the strong correlations betweenCNS and periph-
eral insulin levels found in different animal species (Begg et al.,
2013). This is consistent with the increased insulin levels at the
brain in fasted obese rats (Begg et al., 2013). Insulin also regu-
lates a number of systemic functions via activation of the para-
sympathetic pre-ganglionic nerves at the dorsal vagal complex
(DVC), which comprises the DMV, nucleus tract solitary (NTS),
and area postrema (AP) (Filippi et al., 2012). Although the IR iswidely expressed at NA, DMV (Havrankova et al., 1978; Unger
et al., 1991; Werther et al., 1987), and cholinergic nerves
(Wang et al., 2009), the central regulatory actions of insulin
through these nuclei on bronchial reactivity remain unknown.
Given the abundance of airway-related cholinergic nerves in
the central areas and the increased ACh levels in the lungs of
high-fat diet (HFD) obese mice (Arteaga-Solis et al., 2013), we
aimed to investigate the modulation of cholinergic output into
the airways by central insulin via ARPF activation and its implica-
tion for the pathogenesis of obesity-related asthma. We show
here that intracerebroventricular (ICV)-injected insulin increases
mice airway reactivity and that ICV insulin immunoneutralization
restores airway reactivity in hyperinsulinemic obese mice. The
insulin-induced AHR in obese mice is secondary to the stimula-
tion of ERK signaling at ARPFs located at the DMV and NA,
which convey parasympathetic outflow to the lungs.Cell Reports 11, 934–943, May 12, 2015 ª2015 The Authors 935
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Figure 2. Central Hyperinsulinemia Causes AHR in Mice
(A–E) Measurements of (A) Rrs, (B) Raw, (C) Gtis, (D) Ers, and (E) Htis 30 min after ICV microinjection of saline or insulin at 0.2, 2, or 20 mU in C57BL6/J wild-type
(WT) mice are shown (*p < 0.05, **p < 0.01 compared to group injected with saline; n = 7).
(F–J) Measurements of (F) Rrs, (G) Raw, (H) Gtis, (I) Ers, and (J) Htis in control and DIO groups microinjected via ICV with either anti-Igg or Affibody anti-insulin are
shown (*p < 0.05, **p < 0.01, ***p < 0.001 compared to control + Anti-Igg group; #p < 0.05 when comparing DIO + Affibody anti-insulin group with DIO + anti-Igg
group; n = 5).
See also Figure S2.RESULTS
High-Fat-Fed Obese Mice Exhibit AHR Regardless of
Inflammatory Cell Infiltration
Four-weeks aging C57BL6/J male mice were made obese by
feeding a high-fat diet during 12 weeks. At the end of this period,
mice developed obesity and presented hyperinsulinemia (Fig-
ures S1A–S1D), insulin resistance, and glucose intolerance (Fig-
ures S1E–S1H). Although there are some controversies related
to insulin levels in CNS after a high-fat diet, these discrepancies
seems to be related to the animal model used, but in fasted high-
fat-fed obese rodents there are remarkable increases in fasted
insulin levels in the brain (2-fold increase), which correlate with
serum insulin levels (Begg et al., 2013). We further evaluated
the pulmonary mechanics of control and diet-induced obese
(DIO) mice by measuring airways resistance (Raw), resistance
of the respiratory system (Rrs), tissue resistance (Gtis), elastance
of the respiratory system (Ers), and tissue elastance (Htis). Meth-
acholine produced a significant increase in airway reactivity in
both groups (Figures 1A–1E; Figures S2I–S2M). However, all
the mechanical parameters were significantly greater in DIO
mice (Figures 1A–1E), which is in accordance with previous
studies (Arteaga Solis et al., 2013; Johnston et al., 2008).
Histological evaluation in lungs of both groups revealed
neither lung infiltration by inflammatory cells (Figures 1F and
1G) nor airway remodeling, as evaluated by measuring collagen
and elastic tissue contents by pycrosirius and oxidized resorcin-
fuchsin staining, respectively (Figures 1H–1M). In accordance,
the number of total inflammatory cells, eosinophils, mast cells,
and neutrophils in the bronchoalveolar lavage fluid (BALF) did
not differ between control and DIO groups (Figures S1N–S1Q),936 Cell Reports 11, 934–943, May 12, 2015 ª2015 The Authorsconfirming that innate AHR in our animal model does not
rely on inflammatory cell infiltration. We further moved on to
investigate whether the increase in airway responsiveness was
due to local bronchial hyperreactivity. For this purpose, we
performed concentration-response curves to methacholine
(0.001–100 mM) in isolated bronchus rings isolated from lean
and DIO mice. No changes in the bronchial smooth muscle con-
tractile responses between lean and DIO mice were found (Fig-
ure 1N), indicating that in vivo AHR is not secondary to local
hypercontractility.
HighLevels ofCentral Insulin ProduceAHRbyActivating
Cholinergic Nerves
Besides increased plasma glucose levels, obese/insulin-resis-
tant subjects usually present a compensatory hyperinsulinemia,
which may lead to plenty of secondary complications, such as
cancer, cardiovascular diseases, and benign prostatic hyperpla-
sia (Contreras et al., 2010; Heuson et al., 1972; Heuson and Le-
gros, 1972; Vikram et al., 2010). At the level of the CNS, insulin
regulates food intake, body weight, reproduction, and adiposity
along with other peripheral functions, such as gastric motility
(Blake and Smith, 2012; Brown et al., 2006; Bru¨ning et al.,
2000; Koch et al., 2008). As we did not detect changes in local
bronchial reactivity, tissue remodeling, and inflammatory status
in DIO mice, we hypothesized that elevated levels of insulin in
the CNS lead to an increased cholinergic output into the airways
causing an exacerbated bronchoconstriction in these animals.
Therefore, we next moved to assess whether ICV-delivered in-
sulin increases the pulmonarymechanics in both control andDIO
mice. In control mice, we found that insulin injected 30 min
before the pulmonary mechanics measurements significantly
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Figure 3. Central Insulin Potentiates Methacholine-Induced Bronchoconstriction through the Activation of Cholinergic Neurons
(A–E) Measurements of (A) Rrs, (B) Raw, (C) Gtis, (D) Ers, and (E) Htis, assessed in sham and VX mice, 30 min after ICV microinjection of either saline or insulin
(2 mU) are shown (*p < 0.05, **p < 0.01 compared to sham + saline group; #p < 0.05 when comparing VX + insulin with sham + insulin groups; n = 5).
(F–J) Measurements of (F) Rrs, (G) Raw, (H) Gtis, (I) Ers, and (J) Htis in VAChT KDHOM/micemicroinjected via ICVwith either saline or insulin (2 mU) 30min prior to
the experiment are shown (n = 4–5).
(K) Concentration-response curves to methacholine in the absence or presence of pre-incubated ACh (1, 3, and 10 nM) in bronchial rings from control mice are
shown.
(L) Maximal responses (Emax) to methacoline in the absence and presence of pre-incubated ACh (1, 3, and 10 nM) are shown.
(M) Representative traces of the contractions induced by methacholine in the absence or presence of pre-incubated ACh are shown (*p < 0.05, **p < 0.01
compared to non-treated bronchial rings). All data are expressed as mean ± SEM.
See also Figure S3.increased Rrs, Raw, Gtis, Ers, and Htis, at concentrations of
2 and 20 mU (p < 0.05) (Figures 2A–2E), indicating that centrally
injected insulin is capable of potentiating bronchoconstriction
in response to inhaled methacholine. We also measured
serum insulin levels 30 min after ICV insulin microinjection,
but found no changes either in serum insulin (0.44 ± 0.1 and
0.37 ± 0.1 ng/ml before and after ICV insulin injection, respec-
tively; n = 5) nor in plasma glucose (141.0 ± 1.4 and 146.8 ±
3.0 mg/dl before and after ICV insulin injection, respectively;
n = 5) compared to basal levels (Figures S2A and S2B), confirm-
ing that insulin-induced increases in mechanical parameters in
control mice are not a consequence of the peripheral actions
of insulin. As opposed to control mice, ICV-injected insulin did
not produce any changes in AHR in DIO mice (Figures S2C–
S2G), probably due to local insulin resistance. However, upon
immunoneutralization of central insulin by using an Affibody
anti-insulin ICV, applied 30 min before mechanical measure-ments, we detected a full restoration of the airway reactivity of
DIO mice with no changes in control mice (Figures 2F–2J). ICV
injection of Affibody anti-insulin did not change blood glucose
levels (Figures S2H and S2I).
To evaluate whether central insulin effects were mediated
through the activation of a cholinergic innervation, we first per-
formed ICV insulin injection in bilateral cervical vagotomized
(VX) control mice. ICV-injected insulin produced consistent
bronchoconstriction in the sham group, while it failed to induce
AHR in the VX group (Figures 3A–3E). Bilateral vagotomy also
normalized airway reactivity in response to methacholine in
DIO mice (Figures S3A–S3E). Next, we used vesicle ACh trans-
porter (VAChT) knockdown mice (VAChT KDHOM/), which
have an approximately 70% reduction in the release of ACh
(Prado et al., 2006), to evaluate the bronchial reactivity. Insulin
failed to increase methacholine-induced bronchoconstriction in
VAChT KDHOM/ mice (Figures 3F–3J), while it produced a fullCell Reports 11, 934–943, May 12, 2015 ª2015 The Authors 937
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Figure 4. ERK, but not PI3K, Inhibitor Protects Mice against Insulin-Induced AHR
(A–E) Measurements of (A) Rrs, (B) Raw, (C) Gtis, (D) Ers, and (E) Htis 30 min after ICV microinjection of insulin (2 mU) in the presence or absence of PI3K inhibitor
wortmannin (30 nM) in C57BL6/J WT mice are shown (*p < 0.05 compared to group injected with saline).
(F–J) Comparisons of all pulmonary mechanical parameters 30 min after ICV microinjection of insulin (2 mU) in the presence or absence of MEK/ERK inhibitor
PD98059 (100 mM) in C57BL6/J WT mice are shown (*p < 0.05 compared to group injected with saline; #p < 0.05 when comparing insulin + PD98059 group with
insulin group).
(K–O) Assessments of pulmonary mechanics in DIO mice microinjected via ICV with either saline or PD98059 (100 mM) 30 min prior to the experiment are shown.
Data are expressed as mean ± SEM (n = 5–7; #p < 0.01 compared to DIO + saline group).bronchoconstriction in the correspondent C57BL6/N3 back-
ground mice (Figures S3F–S3J).
As we did not observe a significant increase in the basal airway
reactivity in either obese mice or control mice stimulated with in-
sulin, we further aimed to assess whether a concentration of ACh
that is not able to increase the bronchial reactivity per se can
potentiate the methacholine-induced dose-response contrac-
tions in ex vivo preparations of bronchial rings mounted in organ
baths. We first tested different ACh concentrations (1, 3, 10, and
30 nM), and found that only 30 nMwas capable of directly produc-
ing bronchial contraction (data not shown, n = 4). We next per-
formed concentration-response curves to methacholine in the
absence or presence of pre-incubated ACh at the concentrations
that were unable to produce bronchoconstriction (1, 3, and
10 nM). We found that methacholine-induced contractions were
significantly potentiated by ACh at 3 nM (p < 0.05) and 10 nM
(p < 0.01), whereas a trend to increase was observed with 1 nM
(p = 0.069) pre-incubated ACh (Figures 3K–3M), suggesting that
even low concentrations of ACh, which are unable to induce
brochoconstriction per se, are capable of potentiatingmethacho-
line-induced bronchoconstriction. These data explain why both
obesity-associated central hyperinsulinemia and centrally applied
insulin potentiate in vivo bronchial contractile responses to meth-
acholine in a cholinergic-dependent manner, without changing938 Cell Reports 11, 934–943, May 12, 2015 ª2015 The Authorsbasal lung tone. We also performed concentration-response
curves to methacholine in the presence of pre-incubated ACh in
obese mice. We found that ACh potentiated contractile re-
sponses to methacholine in the DIO group to the same extent
as in the control group (Figures S3K and S3L), indicating that
bronchus from DIO mice is not more sensitive to ACh than the
controls, once more proving that local bronchial hypersensitivity
to cholinergic agonists does not drive AHR in obese mice.
ICV Insulin Induces Bronchoconstriction by Activating
ERK in the CNS
IRs and downstream PI3K/AKT and MAPK signaling effectors
are all expressed throughout the brain (Filippi et al., 2012; Folli
et al., 1994; Pardini et al., 2006). Insulin microinjection into the
DVC activates ERK1/2, triggering a signaling cascade to lower
hepatic glucose production (Filippi et al., 2012). With these
concepts in mind, we tested the hypothesis that central actions
of insulin were due to stimulation of the ERK1/2 pathway in
cholinergic nerves. We first performed insulin ICV injections in
the presence and absence of either the PI3K inhibitor wortman-
nin (30 nM) or the ERK inhibitor PD98059 (100 mM), after which
lung mechanical parameters were evaluated. In control (lean)
mice, wortmannin failed to reduce insulin-induced bronchocon-
striction (Figures 4A–4E), whereas PD98059 prevented central
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Figure 5. Insulin-Induced AHR Occurs via ERK Pathway Activation
(A and B) (A) Body weight and (B) plasma insulin levels in control and DIO mice intracerebroventricularly treated with siSCR or siERK1/2 are shown (n = 5).
(C and D) Representative (C) blots and (D) bar graphs expressing in percentage (%) of reduction of ERK1/2 protein expression in the brain stem from control and
DIO mice intracerebroventricularly treated with siERK1/2 are shown (n = 5).
(E–I) Measurements of (E) Rrs, (F) Raw, (G) Gtis, (H) Ers, and (I) Htis 30min after ICVmicroinjection of insulin (2 mU) in siSCR and siERK groups are shown (#p < 0.01
compared to siSCR + insulin group; n = 5).
(J–N) Assessments of pulmonary mechanics in control siSCR, control siERK, DIO siSCR, and DIO siERK groups are shown (*p < 0.05, **p < 0.01, ***p < 0.001
compared to control siSCR; # p < 0.05 when comparing DIO siERK with DIO siSCR group [two-way ANOVA]). All data are expressed as mean ± SEM (n = 5–7).insulin-induced AHR (Figures 4F–4J). In DIO mice, microinjec-
tions of PD98059 also fully restored the airways’ response (Fig-
ures 4K–4O). ICV injection of PD98059 did not modify blood
glucose levels (Figures S4A and S4B).
To confirm these data, we treated obese and control mice with
either a small interfering RNA (siRNA) for ERK1 and 2 (siERK1/2)
or the scrambled siRNA (siSCR) via ICV during 3 days prior to
lung mechanical evaluation. Obese mice did not change body
weight and serum insulin levels (Figures 5A and 5B), and the
reduction of ERK1/2 expression achieved in the brain stem of
both control and DIO mice was around 60% (Figures 5C and
5D). Insulin elevated AHR in the siSCR group, but failed to pro-
duce AHR in siERK1/2 mice (Figures 5E–5I). AHR was increased
in the DIO siSCR group, whereas siERK1/2 normalized all the al-
terations of the pulmonary mechanics (Figures 5J–5N).
Central Hyperinsulinemia Activates the ERK-Signaling
Pathway in Cholinergic Neurons Situated on the DMV
and NA
Next, we evaluated insulin signal transduction in airway-related
nuclei that projects parasympathetic nerves into the lung. For
this purpose, we assessed IR and ERK1/2 phosphorylation un-
der basal and insulin-stimulated conditions through immunoflu-
orescence. ICV-injected insulin produced a phosphorylation of
IR (p-IRb) and ERK1/2 (p-ERK1/2) in the DMV and rNA (Figures
6A–6D). Moreover, both p-IRb and p-ERK1/2 co-localized with
choline acetyltransferase (ChAT) staining, a well-known markerof cholinergic nerves (Figures 6A–6D), reinforcing that insulin
activates cholinergic nerves at both the DMV and NA via the
ERK/1/2 pathway, thus producing AHR.
As our images revealed that DMV and NA were responsive to
insulin stimulation, we next separately dissect the DVC and the
ventral bulb (VB), which are the regions where the DMV and
NA are located, respectively, to explore the insulin-signaling
pathway under basal and insulin-stimulated conditions. While
ICV-injected insulin produced p-IRb, phosphorylation of AKT
(p-AKT), and p-ERK in the control group at both the DMV and
NA, it did not change phosphorylation levels of these proteins
in the DIO group (Figures 7A–7F). On the other hand, basal IR,
AKT, and ERK phosphorylation were higher in DIO mice
compared to control mice (Figures 7A–7F).
DISCUSSION
There appears to be at least two distinct asthma phenotypes of
obese patients: (1) those with early-onset asthma and high
serum IgE (TH2-high) and (2) those with late-onset asthma and
low serum IgE (TH2-low). The incidence of this last phenotype
highlighted the possibility that non-TH2 components are likely
to co-regulate airway dynamics under pathological conditions,
and that the pathophysiology of obesity-related asthma might
involve both non-TH2 and endocrine pathways. In fact, a non-
TH2 but also inflammatory phenotype, involving innate immunity
rather than adaptive immunity, has been described as aCell Reports 11, 934–943, May 12, 2015 ª2015 The Authors 939
Figure 6. Insulin Promotes Phosphorylation of IR and ERK in Cholinergic Neurons Located at the NA and DMV
(A) Immunofluorescence shows p-IRb, ChAT, and merge in the DMV of mice microinjected with either saline or insulin (2 mU) via ICV 10 min prior to dissection
(n = 4).
(B) Immunofluorescence shows p-ERK, ChAT, and merge in the DMV (n = 4).
(C) Immunofluorescence shows p-IRb, ChAT, and merge in the NA (n = 4).
(D) Immunofluorescence shows p-ERK, ChAT, and merge in the NA (n = 4).component facilitating AHR in obesity (Kim et al., 2014; Kasahara
et al., 2014). On the other hand, an inflammation-independent
neuroendocrine system is capable of regulating airway tone
and participating in the pathogenesis of obesity-related asthma
phenotype. In the present study, we added an important concept
regarding the neuroendocrine regulation of the airway reactivity
in obesity by demonstrating that either central hyperinsulinemia
secondary to obesity or ICV-injected insulin is able to increase
AHR by stimulating ARPFs at the DMV and NA via the ERK
pathway. Moreover, our data show an increase in all lung me-
chanical parameters in response to ICV-injected insulin, in-
cluding Gtis and Htis, indicating that central insulin is capable
of modulating not only the more calibrous bronchial branches,
but also the responsiveness of the very distal bronchioles and
lung tissue. Notwithstanding, small diameter airways are known
to be richly innervated by cholinergic fibers, which are the main
mediators of airway contraction (Canning, 2006).
Although the direct delivery of insulin into the brain is poten-
tially pharmacological, our demonstration that neutralization of
centrally circulating insulin prevents the hyperinsulinemia-in-
duced AHR in the DIO group highlights the relevance of insulin
action at ARPFs in these animals. The mechanical pulmonary
parameters did not change in normoinsulinemic control mice
after insulin neutralization, confirming that excessive rather
than physiological levels of serum insulin are responsible for940 Cell Reports 11, 934–943, May 12, 2015 ª2015 The AuthorsARPF-mediated AHR. In addition, regardless of the body weight
of the animal, central hyperinsulinemia is capable of potentiating
bronchoconstriction per se. Our findings are consistent with
recent studies conducted in either humans or mice reporting
that hyperinsulinemia can be regarded as an independent risk
factor for AHR (Nie et al., 2014; Thuesen et al., 2009).
High-fat-fed obesemice were reported to have increased ACh
levels in the lungs, indicating an increased parasympathetic ac-
tivity in the lungs of these animas (Arteaga-Solis et al., 2013). In
our study, we found that insulin effects on lung reactivity rely on
cholinergic innervation, which is projected to the lungs through
ARPFs. Accordingly, ICV-injected insulin failed to potentiate
methacholine-induced bronchoconstriction in both VX and
VAChT KDHOM/ mice, indicating that central insulin produces
AHR by activating pre-ganglionic cholinergic nerves, thus
increasing cholinergic outflow into the lungs. Peripheral firing
of autonomic cholinergic nerves may not be excluded as an
additional mechanism facilitating AHR in obesity/hyperinsuline-
mic condition (Nie et al., 2014). However, we showed no in-
creases in peripheral serum insulin after ICV injection of insulin,
reinforcing that the herein-observed insulin effects were indeed
a consequence of its central excitatory activity instead of its pe-
ripheral actions.
IR stimulation by insulin leads to the recruitment and phos-
phorylation of receptor substrates such as IRS and Shc proteins.
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Figure 7. Central Hyperinsulinemia Increases Phosphorylation of IR and ERK in Airway-Related Pre-ganglionic Cholinergic Neurons
(A and C–E) Representative (A) blots and protein expression of (C) p-IRb, (D) p-AKT, and (E) p-ERK in the DVC of control and DIO groups microinjected with saline
or insulin (2 mU) via ICV 10 min prior to dissection are shown.
(B and F–H) Representative (B) blots and protein expression of (F) p-IRb, (G) p-AKT, and (H) p-ERK in the VB of control and DIO groupsmicroinjected with saline or
insulin (2 mU) via ICV 10 min prior to dissection are shown. Data are expressed as mean ± SEM of 4–6 animals (*p < 0.05 compared to non-stimulated control
group).
(I) Central insulin activates ERK-signaling pathway in the rNA and DMV at the brain stem, increasing ACh release into the lungs, thus producing AHR through the
stimulation of M3 muscarinic receptors.By one side, Shc activates the Ras-MAPK pathway, activating
ERK1/2, whereas by the other side, IRS (1/2/3) proteins mostly
activate the PI3K-Akt pathway by recruiting and activating
PI3K, leading to the generation of secondmessenger PIP3 (Klein-
ridders et al., 2014; Rask-Madsen and Kahn, 2012). Membrane-
bound PIP3 recruits and activates PDK-1, which phosphorylates
and activates Akt. Our data suggest that insulin recruits ERK1/2
to activate cholinergic nerves instead of PI3K/Akt, as the cen-
trally applied insulin failed to produce AHR when injected either
in the presence of the ERK inhibitor PD98059 or in siERK1/2-
treated mice, whereas the PI3K inhibitor wortmannin had no ef-
fect. Although we consistently showed the dependence of ERK
activation for the central insulin-mediated AHR, we cannot
neglect that inhibition/deletion of the ERK-signaling pathway in
the brain stem alsomay blunt the shuttling of blood-borne insulin
into the cerebrospinal fluid (CSF). Such ERK-dependent trans-
port of circulating leptin into the CSF recently has been shownto be operated by tanycytes in the hypothalamus (Balland
et al., 2014). Tanycyte-like cells are known to also reside in the
AP, which lies next to the DVC (Langlet et al., 2013). Along with
these genetic and pharmacological evidences, we have demon-
strated that centrally applied insulin induces phosphorylation of
IR and ERK in the cholinergic neurons located at the DMV and
NA. ERK is overactivated by excessive insulin levels in the
CNS of high-fat-fed obese rats (Filippi et al., 2012). Our results
matcheswith this concept, as IR and ERKphosphorylation levels
were upregulated at basal state in the obese group. Moreover,
it is likely that the IR/ERK-signaling pathway was maximally
activated in the brain stem of DIO mice, as it did not respond
to additional insulin stimulation (Figures 4E–4L), explaining why
additional ICV insulin infusion into already hyperinsulinemic
DIO mice did not produce additional AHR.
Collectively, our findings indicate that central insulin activates
the ERK pathway in cholinergic ARPFs, producing an increaseCell Reports 11, 934–943, May 12, 2015 ª2015 The Authors 941
in parasympathetic outflow into the lungs and yielding AHR
(Figure 4M). This study narrows down the effect of obesity and
hyperinsulinemia on AHR via a specific signaling pathway in a
discreet area of the brain. The presence of this non-TH2 compo-
nent in obesity-related asthma explains why most of obese sub-
jects are resistant to glucocorticoid drug treatment. The present
knowledge may drive new therapeutic strategies for the treat-
ment of this peculiar asthma phenotype.
EXPERIMENTAL PROCEDURES
Animals
All animal procedures and experimental protocols were in accordance with
the Ethical Principles in Animal Research adopted by the Brazilian College
for Animal Experimentation (COBEA) and were approved by the institutional
Committee for Ethics in Animal Research/State University of Campinas
(CEEA-UNICAMP). C57BL6/J mice were used. Animals were fed for 12–
14 weeks with either a standard chow or a high-fat diet to induce obesity.
We also used vesicle ACh transporter (VAChT) homozygous knockdown
mice (VAChT KDHOM/) (Prado et al., 2006).
ICV Injections and Pulmonary Mechanics
Mice were previously anesthetized with a mix of ketamine and xylazin. After
that, mice were stereotaxically instrumented (Stoelting Apparatus) to implant
stainless steel 26G cannulas in the right lateral ventricle. The coordinates
used from the bregma were: anterior/posterior, 0.4 mm; lateral, 0.8 mm; and
dorso/ventral, 2.0 mm. After 5 days of recovery, mice were utilized for the pul-
monary mechanics measurements.
For this purpose, we used the forced oscillation technique with a FlexiVent
(SCIREQ). The mice were sedated with an intraperitoneal (i.p.) injection of tio-
pental (33 mg/kg). A tracheostomy was done with an 18G cannula, and the
mouse was connected to the FlexiVent. The procedure was done in mice
with closed chest. The mice were ventilated at 150 Hz, tidal volume (VT) 10
l/kg, and positive end-expiratory pressure (PEEP) level of 3 cmH2O. In obese
mice over 30 g, a VT of 0.3 ml was used to avoid hyperinflation of the lung
due to VT calculated from their exaggerated body weights. Dose-response
curves to inhaled methacholine chloride (Sigma) were done in increasing con-
centrations (6.25, 12.5, 25.0, and 50.0 mg/ml). The following mechanical pa-
rameters were evaluated: Rrs, Raw, Gtis, Ers, and Htis.
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